Shahin Akhondzadeh
#153,838
Most Influential Person Now
Researcher
Shahin Akhondzadeh's AcademicInfluence.com Rankings
Shahin Akhondzadehcomputer-science Degrees
Computer Science
#8297
World Rank
#8723
Historical Rank
Machine Learning
#3361
World Rank
#3401
Historical Rank
Artificial Intelligence
#3659
World Rank
#3711
Historical Rank
Database
#5319
World Rank
#5520
Historical Rank
Download Badge
Computer Science
Shahin Akhondzadeh's Degrees
- PhD Computer Science University of Tehran
- Masters Artificial Intelligence Sharif University of Technology
- Bachelors Computer Engineering Amirkabir University of Technology
Similar Degrees You Can Earn
Why Is Shahin Akhondzadeh Influential?
(Suggest an Edit or Addition)Shahin Akhondzadeh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial (2009) (350)
- Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial (2003) (323)
- Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial (2004) (299)
- Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] (2004) (293)
- Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. (2005) (280)
- Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial (2007) (278)
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. (2012) (273)
- Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial (2003) (258)
- Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial (2007) (234)
- Passionflower in the treatment of generalized anxiety: a pilot double‐blind randomized controlled trial with oxazepam (2001) (228)
- Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. (2006) (225)
- Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16‐week, randomized and placebo‐controlled trial (2010) (208)
- A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease (2009) (203)
- Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double‐blind, randomised and placebo‐controlled trial (2008) (198)
- Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371] (2004) (188)
- Herbal medicine in the treatment of Alzheimer's disease (2006) (133)
- Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial (2003) (132)
- Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia (2006) (120)
- Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial (2003) (120)
- Pioglitazone Adjunctive Therapy for Moderate-to-Severe Major Depressive Disorder: Randomized Double-Blind Placebo-Controlled Trial (2012) (119)
- Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. (2013) (117)
- A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. (2014) (116)
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study (2013) (116)
- Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial (2012) (115)
- Glutathione-related factors and oxidative stress in autism, a review. (2012) (114)
- Prevalence of obsessive-compulsive disorder in Iran (2004) (108)
- Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism (2010) (107)
- Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study (2013) (107)
- Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial (2012) (106)
- Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder (2010) (106)
- Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double‐blind randomized clinical trial (2014) (103)
- Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. (2013) (103)
- PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL (2015) (100)
- Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial (2009) (99)
- Dipyridamole in the treatment of schizophrenia: adenosine–dopamine receptor interactions (2000) (98)
- Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression (2013) (98)
- Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia (2012) (96)
- Mental Health Survey of the Iranian Adult Population in 2015. (2017) (94)
- Cardiovascular Effects of Saffron: An Evidence-Based Review (2011) (90)
- Comparing Effects of Ketamine and Thiopental Administration During Electroconvulsive Therapy in Patients With Major Depressive Disorder: A Randomized, Double-Blind Study (2014) (88)
- Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study (2014) (87)
- Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. (2011) (87)
- N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety (2015) (87)
- Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial (2010) (84)
- Saffron: The Golden Spice with Therapeutic Properties on Digestive Diseases (2019) (83)
- Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial (2005) (83)
- Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial (2008) (82)
- Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. (2006) (81)
- Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study. (2012) (80)
- Passionflower in the treatment of opiates withdrawal: a double‐blind randomized controlled trial (2001) (80)
- N‐acetylcysteine augmentation therapy for moderate‐to‐severe obsessive–compulsive disorder: randomized, double‐blind, placebo‐controlled trial (2016) (79)
- A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder (2009) (79)
- Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder (2011) (79)
- Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial (2015) (77)
- Hippocampal synaptic plasticity and cognition (1999) (74)
- Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial (2003) (74)
- Next generation sequencing: implications in personalized medicine and pharmacogenomics. (2016) (73)
- Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia (1999) (73)
- Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study (2008) (71)
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial. (2016) (71)
- Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial (2016) (69)
- The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial (2010) (67)
- Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review (2013) (64)
- Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial (2014) (62)
- Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial (2016) (60)
- A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder (2008) (60)
- The 5-HT hypothesis of schizophrenia. (2001) (60)
- Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial (2016) (58)
- The effect of saffron (Crocus sativus L.) hydroalcoholic extract on metabolic control in type 2 diabetes mellitus: A triple-blinded randomized clinical trial (2018) (56)
- Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial (2012) (56)
- Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder (2012) (55)
- Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease. (2013) (54)
- A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism (2015) (53)
- A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia (2008) (51)
- Cyproheptadine in the treatment of autistic disorder: a double‐blind placebo‐controlled trial (2004) (51)
- Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial (2015) (51)
- Double‐blind randomized parallel‐group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression (2011) (50)
- Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: Randomized, Double-Blind, Placebo-Controlled Study (2013) (50)
- Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: A 17-year experience (2004) (49)
- Aspirin for treatment of lithium‐associated sexual dysfunction in men: randomized double‐blind placebo‐controlled study (2013) (47)
- Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial (2013) (47)
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial. (2018) (46)
- Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial. (2016) (46)
- Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial (2015) (45)
- Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial (2011) (45)
- Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial (2018) (44)
- Minocycline combination therapy with fluvoxamine in moderate‐to‐severe obsessive–compulsive disorder: A placebo‐controlled, double‐blind, randomized trial (2016) (44)
- Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents (2005) (44)
- Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial. (2015) (44)
- The role of phthalate esters in autism development: A systematic review. (2016) (43)
- A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders (2012) (43)
- Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: Randomized, double‐blind, placebo‐controlled study (2016) (42)
- Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches (2007) (42)
- Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial (2014) (41)
- Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders (2007) (41)
- The Reliability and Validity of the Persian Version of Three-Factor Eating Questionnaire-R18 (TFEQ-R18) in Overweight and Obese Females (2017) (40)
- A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia (2013) (40)
- Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial. (2007) (40)
- Curcumin Gel in the Treatment of Minor Aphthous Ulcer: a Randomized, Placebo- Controlled Trial (2012) (39)
- Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder (2014) (38)
- Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal. (2000) (38)
- A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia (2014) (38)
- The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial. (2018) (38)
- Interaction between adenosine and GABAA receptors on hippocampal neurones (1994) (38)
- Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism: A 10-Week Randomized Study (2013) (37)
- Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients (2015) (37)
- Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial. (2016) (36)
- Double‐blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal (2000) (36)
- Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double‐blind randomized placebo‐controlled study (2008) (36)
- The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial (2016) (35)
- Melatonin decreases olanzapine induced metabolic side-effects in adolescents with bipolar disorder: a randomized double-blind placebo-controlled trial. (2014) (34)
- The Role of Lead Exposure on Attention-Deficit/ Hyperactivity Disorder in Children: A Systematic Review (2016) (34)
- Medical Science and Research in Iran. (2017) (33)
- A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania. (2017) (33)
- Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial (2010) (33)
- Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. (2018) (32)
- Schizophrenia: etiology and pharmacotherapy. (2001) (32)
- Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co-administration: Through circadian cycle modification or appetite enhancement? (2012) (32)
- The effect of saffron (Crocus sativus L.) hydro-alcoholic extract on liver and renal functions in type 2 diabetic patients: A double-blinded randomized and placebo control trial (2017) (32)
- Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial (2017) (31)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO - CONTROLLED STUDY OF SAFETY OF THE ADJUNCTIVE SAFFRON ON SEXUAL DYSFUNCTION INDUCED BY A SELECTIVE SEROTONIN REUPTAKE INHIBITOR (2011) (31)
- Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial (2015) (31)
- Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study (2012) (31)
- Effect of memantine combination therapy on symptoms in patients with moderate‐to‐severe depressive disorder: randomized, double‐blind, placebo‐controlled study (2017) (30)
- Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. (2018) (30)
- Efficacy of theophylline compared to methylphenidate for the treatment of attention‐deficit hyperactivity disorder in children and adolescents: a pilot double‐blind randomized trial (2004) (30)
- Baclofen versus clonidine in the treatment of opiates withdrawal, side‐effects aspect: a double‐blind randomized controlled trial (2001) (30)
- Lead poisoning in a West Bank Arab Village. (1984) (30)
- Opioid Use Disorder Induces Oxidative Stress and Inflammation: The Attenuating Effect of Methadone Maintenance Treatment (2018) (29)
- Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. (2017) (29)
- A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia. (2015) (28)
- Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial (2014) (27)
- Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation in ECM1 (2015) (27)
- Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial. (2017) (27)
- Alzheimer's disease: pathophysiology and pharmacotherapy. (2002) (27)
- Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial (2011) (27)
- A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia (2008) (27)
- Association between physical activity and mental health among high-school adolescents in Boushehr province: A population based study (2011) (27)
- Is transcranial direct current stimulation an effective modality in reducing food craving? A systematic review and meta-analysis (2020) (27)
- L‐carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double‐blind study (2017) (26)
- Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study. (2013) (26)
- Iranian science shows world's fastest growth: ranks 17th in science production in 2012 (2013) (26)
- A REVIEW ON MEDICINAL PLANT OF GLYCYRRHIZA GLABRA L (2013) (26)
- A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia (2012) (26)
- Celecoxib for the treatment of mild‐to‐moderate depression due to acute brucellosis: a double‐blind, placebo‐controlled, randomized trial (2015) (25)
- Cyproheptadine in treatment of chronic schizophrenia:a double‐blind, placebo‐controlled study (1999) (25)
- Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial (2017) (25)
- Nutrients for prevention and treatment of mental health disorders. (2013) (24)
- A Double-Blind, Randomized, and Placebo-Controlled Trial of Buspirone Added to Risperidone in Patients With Chronic Schizophrenia (2010) (24)
- Knowledge, attitude and practice of herbal remedies in a group of infertile couples. (2013) (24)
- Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double‐blind trial (2010) (24)
- Role of Melatonin in Body Weight: A Systematic Review and Meta-Analysis. (2017) (24)
- Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce (2022) (24)
- Induction of a novel form of hippocampal long‐term depression by muscimol: involvement of GABAA but not glutamate receptors (1995) (24)
- Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial. (2014) (23)
- l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. (2017) (23)
- Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double‐blind, randomized trial (2005) (23)
- Pharmacotherapy of Schizophrenia: The Past, Present and Future (2006) (23)
- L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial. (2014) (23)
- Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy. (2006) (23)
- Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double‐blind and placebo‐controlled randomized trial (2019) (22)
- A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression (2020) (22)
- Short-term Outcomes of Saffron Supplementation in Patients with Age-related Macular Degeneration: A Double-blind, Placebo-controlled, Randomized Trial (2016) (22)
- Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study. (2019) (22)
- Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial. (2016) (22)
- Double‐blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression (2003) (22)
- PHARMACOTHERAPY OF SCHIZOPHRENIA (2006) (22)
- Change in frequency of acute and subacute effects of ecstasy in a group of novice users after 6 months of regular use. (2013) (22)
- L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial (2018) (21)
- Saffron, passionflower, valerian and sage for mental health. (2013) (21)
- Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy. (2011) (21)
- Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: A randomized clinical trial. (2018) (21)
- Victimization by traditional bullying and cyberbullying and the combination of these among adolescents in 13 European and Asian countries (2021) (21)
- Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study (2013) (21)
- Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders–a double-blind, randomized intervention study (2019) (20)
- AUTISM SPECTRUM DISORDERS: ETIOLOGY AND PHARMACOTHERAPY (2007) (20)
- Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial (2017) (20)
- Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial (2014) (20)
- Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double‐blind, placebo‐controlled clinical trial (2020) (19)
- The Importance of Clinical Trials in Drug Development (2016) (19)
- Trends of Mental Health Status in Iranian Population Aged 15 and above between 1999 and 2015. (2017) (18)
- Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial (2019) (18)
- Disclosure of Attention Deficit Hyperactivity Disorder and its Effect on Rejection of Students by Teachers (2009) (18)
- Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial (2017) (18)
- Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial (2003) (18)
- Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study. (2014) (18)
- Are Supplementation of Omega-3 and Ascorbic Acid Effective in Reducing Oxidative Stress and Depression among Depressed Shift Workers? (2015) (18)
- Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study. (2014) (18)
- Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. (2017) (18)
- Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial. (2013) (17)
- Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study. (2012) (17)
- Total Antioxidant Capacity and Malondialdehyde in Depressive Rotational Shift Workers (2013) (17)
- Infectious agents and different course of multiple sclerosis: a systematic review (2018) (17)
- Memantine versus Methylphenidate in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial (2015) (16)
- Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial (2015) (16)
- L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial. (2020) (15)
- Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial (2019) (15)
- Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial (2011) (15)
- Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial (2017) (15)
- Contribution of Health Researches in National Knowledge Production: A Scientometrics Study on 15-Year Research Products of Iran (2017) (15)
- Renal tubular dysgenesis present in a newborn with meconium ileus. (1994) (14)
- Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia * (2002) (14)
- Efficacy and Safety of Oral Combination of Yohimbine and L-arginine (SX) for the Treatment of Erectile Dysfunction: a multicenter, randomized, double blind, placebo-controlled clinical trial (2010) (14)
- Setting research priorities to achieve long-term health targets in Iran (2018) (14)
- Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial (2012) (14)
- l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. (2018) (14)
- Research Ranking of Iranian Universities of Medical Sciences Based on International Indicators: An Experience From I.R. of Iran. (2017) (13)
- Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study (2016) (13)
- Mental health study process into prevalence of mental disorders in Iran. (2015) (13)
- The Characteristics, Reliability and Validity of the Persian Version of Simplified Nutritional Appetite Questionnaire (SNAQ) (2019) (13)
- Personalized Medicine: A Tailor Made Medicine (2014) (13)
- Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial (2020) (13)
- Oxidative Stress and Depression among Male Shift Workers in Shahid Tondgouyan Refinery (2014) (12)
- Topiramate prevents ecstasy consumption: a case report (2005) (12)
- Antidepressant-like effect of magnetic resonance imaging-based stimulation in mice (2007) (12)
- Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial (2018) (12)
- Attention deficit hyperactivity disorder in imprisoned individuals--a review. (2011) (12)
- Diseases and Health Outcomes Registry Systems in I.R. Iran: Successful Initiative to Improve Public Health Programs, Quality of Care, and Biomedical Research. (2017) (12)
- Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial (2020) (12)
- Influence of citicoline on citalopram-induced antidepressant activity in depressive-like symptoms in male mice (2018) (12)
- Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. (2019) (11)
- Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial (2020) (11)
- Cardiovascular Effects of Allium Sativum (Garlic): An Evidence-Based Review (2008) (11)
- The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways (2020) (11)
- Tincture of opium for treating opioid dependence: a systematic review of safety and efficacy (2017) (11)
- Potentiation of muscimol-induced long-term depression by benzodiazepines and prevention or reversal by pregnenolone sulfate. (1998) (11)
- Ethical Guidelines for Clinical Trials (2006) (11)
- Herbal Medicine in the Treatment of Primary Dysmenorrhea (2015) (11)
- The glutamate hypothesis of schizophrenia (1998) (10)
- Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine. (2009) (10)
- Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control (2018) (10)
- Development of Health Research Structures Over the Last 25 Years: Main Achievements and Challenges. (2017) (10)
- Prospects of Saffron and its Derivatives in Alzheimer's Disease. (2021) (9)
- Avicenna and Evidence Based Medicine (2014) (9)
- Reliability and Validity of the Persian Version of Compulsive Eating Scale (CES) in Overweight or Obese Women and Its Relationship with Some Body Composition and Dietary Intake Variables (2016) (9)
- Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial (2020) (9)
- Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial (2019) (9)
- Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial (2019) (9)
- Glutamate-independent long term depression in rat hippocampus by activation GABAA receptors. (1996) (9)
- Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double‐blind, placebo‐controlled study (2017) (9)
- Combination of clomipramine and nortriptyline in the treatment of obsessive‐compulsive disorder: a double‐blind, placebo‐controlled trial (1998) (8)
- Combination of citalopram and nortriptyline in the treatment of severe major depression: a double-blind, placebo-controlled trial (2007) (8)
- Autism Spectrum Disorders in Iran (2011) (8)
- Major depressive disorder in children and adolescents after renal transplantation. (2009) (8)
- Comparing opium tincture and methadone for medication‐assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double‐blind randomized controlled trial (2019) (8)
- Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials (2021) (8)
- Cyproheptadine in treatment of autism (2002) (8)
- Efficacy and safety of Sophora alopecuroides var. alopecuroides seed extract for opioid detoxification: A randomized, double‐blind, and placebo‐controlled clinical trial (2019) (8)
- 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control (2020) (7)
- Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial (2021) (7)
- Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairments in chronic schizophrenia (2005) (7)
- Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial (2018) (7)
- Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double‐blind, placebo‐controlled clinical trial (2021) (7)
- How to Assess Quality of Research in Iran, From Input to Impact? Introduction of Peer-Based Research Evaluation Model in Iran. (2017) (7)
- Femicomfort in the Treatment of Premenstrual Syndromes: A Double-Blind, Randomized and Placebo Controlled Trial (2010) (7)
- How the US Sanctions Are Affecting the Health Research System in Iran? (2021) (6)
- The Role of Medical Research Centers in Health Research System Promotion in I.R. of Iran: 2001-2014. (2016) (6)
- Potentiation by neurosteroids of muscimol/adenosine interactions in rat hippocampus (1995) (6)
- Comparison of hypericum perforatum and placebo in treatment of physical symptoms of premenstrual syndrome (2004) (6)
- Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial. (2017) (6)
- Sudden hearing loss subsequent to diarrhea: what is the missing link? (2014) (6)
- Role of the methanolic extracts of Boswellia serrata and Lavandula angustifolia on apomorphine induced ejaculation in male Wistar rats. (2010) (6)
- Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial (2020) (6)
- Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double‐blind, placebo‐controlled trial (2020) (6)
- ANTIDEPRESSANT EFFECT OF CROCUS SATIVUS: AN EVIDENCE BASED REVIEW (2010) (6)
- Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control (2020) (6)
- Investigation of Affecting Factors on Persistence in the Treatment of Patients under Methadone Maintenance Therapy in Addiction Therapy Centers, Yazd-Iran (2015) (6)
- Is there a relationship between estrogen serum level and symptom severity throughout the menstrual cycle of patients with schizophrenia (2005) (6)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Tehran, Iran. (2017) (5)
- Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial. (2019) (5)
- Ginkgo biloba for Improvement of Memory and Quality of Life in Multiple Sclerosis: an Open Trial (2011) (5)
- Vitamin E and ginseng combined supplement for treatment of male erectile dysfunction: A double-blind, placebo-controlled, randomized, clinical trial (2019) (5)
- Evaluation of Drug and Alcohol Abuse in People Aged 15 Years and Older in Iran (2020) (5)
- Therapeutic effects of saffron (Crocus sativus) versus fluoxetine on Irritable Bowel Syndrome: A double-blind randomized clinical trial (2019) (5)
- Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial? (2020) (5)
- Red yeast rice as an adjunct to sertraline for treatment of depression in patients with percutaneous coronary intervention: Placebo-controlled trial (2018) (5)
- Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor (1999) (5)
- FEMALE INFERTILITY AND HERBAL MEDICINE (2017) (5)
- Factors Associated with Anxiety in Premature Coronary Artery Disease Patients: THC-PAC Study. (2016) (5)
- Reliability and validity of the Persian version of Food Craving Questionnaire-Trait-Reduced (FCQ-T-r) in overweight and obese women (2018) (5)
- Potentiation of muscimol-induced long-term depression by benzodiazepines but not zolpidem (2002) (5)
- COMPARISON OF DESMOPRESSIN (DDAVP) TABLET AND INTRANASAL SPRAY IN THE TREATMENT OF CENTRAL DIABETES INSIPIDUS (2005) (5)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Mazandaran, Iran. (2017) (4)
- Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double‐blind, placebo‐controlled trial (2022) (4)
- Infectious Agents and Stroke: A Systematic Review (2021) (4)
- Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial (2012) (4)
- Citicoline (CDP‐choline) add‐on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double‐blind, randomized placebo‐controlled trial (2018) (4)
- Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial. (2020) (4)
- Comparison of Stimdate with Ritalin in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial (2009) (4)
- Microbiome and Schizophrenia (2019) (4)
- Muscimol-induced long-term depression in the hippocampus: Lack of dependence on extracellular calcium (1996) (4)
- Health Research Governance: Introduction of a New Web-based Research Evaluation Model in Iran: One-decade Experience (2016) (4)
- Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test (2013) (3)
- Iran’s scientists uncrushed by decades of sanctions (2018) (3)
- Delirium Associated with Donepezil in a Patient with Alzheimer's Disease: a Case Report (2013) (3)
- Design and Implementation of a Social Network for Laboratory Researchers (2020) (3)
- Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial. (2021) (3)
- A Tool to Reduce the Problems of Iranian Health Researchers (2020) (3)
- Celecoxib for schizophrenia (2011) (3)
- Possibility for science without borders in the Trump era (2019) (3)
- Establishment of the National Network of WHO Collaborating Centres in Iran to Contribute to the National Public Health Needs. (2015) (3)
- US Editors and Reviewers can no Longer Handle Submissions by Authors Employed by the Government of Iran: Is it Fair and Logical? (2013) (3)
- Do Case Reports Require Ethical Approvals (2017) (3)
- Crocus sativus (saffron), an Herb with a History as Long as the History of Iran with Psychotropic Effects (2016) (3)
- Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial (2022) (3)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Kordestan, Iran. (2017) (3)
- Knowledge, attitude, and practice of Iranian adolescent girls towards 3-4-methylenedioxymethamphetamine. (2011) (3)
- A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. (2020) (3)
- Serum Level of Cortisol, hsCRP and IL-6 in Depressed Rotational Shift Workers (2012) (3)
- Cilostazol as an adjunctive treatment in major depressive disorder: a pilot randomized, double-blind, and placebo-controlled clinical trial (2022) (3)
- Medicinal plants in the treatment of obsessive-compulsive disorder: A review. (2019) (3)
- Trump, COVID-19, Natural Disasters and Health in Iran (2020) (3)
- Maintenance of muscimol-induced long-term depression by neurosteroids (1996) (3)
- Herbal Medicine in the Treatment of Polycystic Ovary Syndrome (2016) (3)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Semnan, Iran. (2017) (3)
- New Hopes for Treatment of Alzheimer’s Disease (2018) (2)
- Research in Iran: An Overview (2017) (2)
- Cardiovascular Effects of Antidepressants and Mood Stabilizers (2007) (2)
- Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial (2021) (2)
- Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial (2021) (2)
- Published research on attention deficit hyperactivity disorder: a comparative analysis of MEDLINE and an Iranian bibliographic database. (2010) (2)
- Research in Iran: Hopes and Disappointments (2017) (2)
- Innovation and Technology in Iran (2017) (2)
- SYSTEMATIC REVIEW ON EFFECT OF GINKGO BILOBA IN THE TREATMENT OF AUTISM (2012) (2)
- Advances in Alternative and Integrative Medicine in the Treatment of Depression: A Review of the Evidence. (2021) (2)
- Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (2018) (2)
- Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial (2022) (2)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Markazi, Iran. (2017) (2)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Kerman, Iran. (2017) (2)
- The Efficacy of Herbal Medicines for Treatment of Hot Flash: A Systematic Review (2017) (2)
- More ACTIONS needed to reach a consensus on adjunctive antidepressant therapy for negative symptoms of schizophrenia (2016) (2)
- Personality Patterns in Narcotics Anonymous Members versus Individuals with Addiction Receiving Methadone Maintenance Therapy (2014) (2)
- Herbal Medicine in the Treatment of Premenstrual Syndromes (2011) (2)
- Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial (2021) (2)
- Possible effects of Saffron (Crocus sativus) in the treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled trial (2022) (2)
- Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability (2021) (2)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Razavi Khorasan, Iran. (2017) (2)
- 5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial (2010) (2)
- Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial (2022) (2)
- Allopurinol as adjunctive treatment for acute mania in hospitalized bipolar patients (2005) (2)
- Is it time to have another look at lithium maintenance therapy in bipolar disorder? (1999) (2)
- Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial (2022) (2)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of South Khorasan, Iran. (2017) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Isfahan, Iran. (2017) (1)
- Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine (2022) (1)
- Vitamin E and ginseng supplementation to enhance female sexual function: a randomized, double-blind, placebo-controlled, clinical trial (2020) (1)
- Allopurinol and related drugs for schizophrenia (2012) (1)
- Repositioning Drugs for Psychiatry (2020) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of North Khorasan, Iran. (2017) (1)
- Monoclonal Antibody a Promising Treatment for Depression (2019) (1)
- Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double‐blind, placebo‐controlled clinical trial (2020) (1)
- The Economic Aspects of Medical Biotechnology (2016) (1)
- Ethical Issues in Medical Biotechnology (2014) (1)
- Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses (2022) (1)
- Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production (2021) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Yazd, Iran. (2017) (1)
- Herbal Medicine in the Treatment of Attention-deficit/Hyperactivity Disorder (2011) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of West Azarbaijan, Iran. (2017) (1)
- ANALYTICAL REVIEW ON PERSIAN POPPY (PAPAVER BRACTEATUM LINDL.) AS A NATIVE AND ECONOMICAL MEDICINAL PLANT (2013) (1)
- Development of Evaluation System for Iranian Health Research Networks: Challenges and Lessons Learned (2020) (1)
- Depression and Inflammation: Is There any Role for Biomarkers? (2019) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of East Azarbaijan, Iran. (2017) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Ardebil, Iran. (2017) (1)
- SELEGILINE IN COMPARISON WITH METHYLPHENIDATE IN TREATMENT OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: A DOUBLE-BLIND, RANDOMIZED TRIAL (2009) (1)
- Hydroxyzine may be safe and effective in generalised anxiety disorder (2003) (1)
- The effects of opium tincture and methadone on the cognitive function of patients with opioid use disorder (2021) (1)
- The Role of Lead Exposure on Attention-Deficit/ Hyperactivity Disorder A Systematic Review (2016) (1)
- Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial (2020) (1)
- Attention deficit hyperactivity disorder in prison. (2009) (1)
- Research in Iran: Look on the Bright Side (2017) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Fars, Iran. (2017) (1)
- Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial (2020) (1)
- Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial (2021) (1)
- The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders (2022) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Khouzestan, Iran. (2017) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Lorestan, Iran. (2017) (1)
- Opium tincture versus methadone for opioid agonist treatment: A randomized controlled trial. (2022) (1)
- The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial (2021) (1)
- Evidence Based Herbal Medicine and Mental Health (2012) (1)
- The Meeting of Psychiatry and Humanities: An Overview (2009) (1)
- A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia (2013) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Kermanshah, Iran. (2017) (1)
- Microbiota and Autism Spectrum Disorder (2019) (1)
- Psychotropic Effects of Saffron: A Brief Evidence-based Overview of the Interaction Between a Persian Herb and Mental Health (2021) (1)
- Herbal Medicine for Women's Health (2015) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Sistan and Bluchestan, Iran. (2017) (1)
- HERBAL MEDICINE FOR TREATING HOT FLASHES (2014) (1)
- Pharmacotherapy of schizophrenia: ploypharmacy approaches. (2010) (1)
- Integrating Psychiatry and Medical Biotechnology as a Way to Achieve Scientific, Precision, and Personalized Psychiatry (2021) (1)
- Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial? (2020) (1)
- Atomoxetine in patients with recurrent vasovagal syncope for preventing vasovagal attacks and improvement of depression and anxiety: a randomized double-blind placebo-controlled clinical trial (2020) (1)
- Significant Reduction in Hospitalization Due to COVID-19 as a Medium-term Outcome Following Coronavirus Vaccination in Iran (2021) (1)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Hamadan, Iran. (2017) (1)
- [Renal tubular dysgenesis]. (1995) (1)
- Efficacy and tolerability of Lavandula angustifolia in treating patients with the diagnosis of depression: a systematic review of randomized controlled trials (2021) (1)
- CASE REPORT: SUDDEN HEARING LOSS SUBSEQUENT TO DIARRHEA: WHAT IS THE MISSING LINK? (2014) (1)
- Intraoperative Administration of Magnesium Sulfate on Post-Operative Pain of Inguinal Herniorrhaphy under General Anesthesia (2013) (1)
- Research in Iran: Quantity and Quality (2017) (0)
- EDITORIAL: EVIDENCE BASED MEDICINE AND HERBAL MEDICINE (2016) (0)
- Evidence for Anti-inflammatory Effects of Adalimumab in Treatment of Patients With Major Depressive Disorder: A Pilot, Randomized, Controlled Trial (2022) (0)
- l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial. (2023) (0)
- A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia (2013) (0)
- Regional Meeting of WHO Collaborating Centers for Mental Health in the Eastern Mediterranean Region. (2017) (0)
- Corrigendum to “Possible effects of Saffron (Crocus sativus) in the treatment of erectile dysfunction: A randomized, double-blind, placebo-controlled trial” [J. Herb. Med. 32 (2022) 100551] (2022) (0)
- Volume 14, Issue 2, Spring 2015 Editorial in Charge (2015) (0)
- Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials (2022) (0)
- The Effect of Concurrent Administration of Typical or Atypical Antipsychotic Drugs and Lithium on Lithium Ratio in Acute Manic Patients (2008) (0)
- The Inflammatory Mechanism in Depression and Some Possible Effective Agents (2022) (0)
- Comparison of the Validity of Intention-To-Treat and Per-Protocol Approaches Using Monte-Carlo Simulation: Secondary Analysis of a Clinical Trial in the Treatment of Schizophrenic Patients in the Presence of Non-Compliance (2014) (0)
- Opium tincture for opioid substitution treatment (2021) (0)
- The Necessity of Preserving the Research System in Emergency Eras. (2021) (0)
- Basic Science and Clinical Studies on Non-COVID-19 Topics, of Coronavirus Victims (2020) (0)
- Author Index (2003) (0)
- OPIUM TRIAL: A MULTICENTRE RANDOMIZED CLINICAL TRIAL COMPARING OPIUM TINCTURE WITH METHADONE FOR MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER (2019) (0)
- trial Galantamine efficacy and tolerability as an augmentative therapy in autistic children : A randomized (2013) (0)
- 9 Autism Spectrum Disorders in Iran (2012) (0)
- A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders (2012) (0)
- [Lead poisoning]. (1983) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Hormozgan, Iran. (2017) (0)
- Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia (2018) (0)
- Medical Biotechnology and Alzheimer’s Disease: New Hopes (2016) (0)
- Herbal Medicine in the Treatment of Obsessive Compulsive Disorder: A Review (2019) (0)
- EDITORIAL: EVIDENCE BASED MEDICINE AND MEDICAL BIOTECHNOLOGY (2015) (0)
- Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines (2022) (0)
- AUTISTIC DISORDERS AND MEDICAL BIOTECHNOLOGY (EDITORIAL) (2015) (0)
- Saffron a Prototype Example for Evidence Based Herbal Medicine (2013) (0)
- Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial (2012) (0)
- Interdisciplinary Collaboration between Bench and Bedside in the COVID-19 Pandemic (2023) (0)
- ETHIICAL ISSUES IN MEDICAL BIOTECHNOLOGY (EDITORIAL) (2014) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Gilan, Iran. (2017) (0)
- Randomized Controlled Trial Omega-3 supplementation effects on body weight and depression among dieter women with comorbidity of depression and obesity compared with the placebo : A randomized clinical trial (2018) (0)
- Substance of choice, impact of heroin or opium on treatment retention in a multicentre randomised controlled trial in Iran. (2022) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Chaharmahal and Bakhtiari, Iran. (2017) (0)
- Integration of Basic Sciences with Clinical Medicine (2018) (0)
- Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial (2023) (0)
- Iran’s scientists uncrushed by decades of sanctions (2018) (0)
- Fc22-04 Effect of folic acid add-on treatment in patients with acute mania on clinical symptoms and urinary 6-sulfatoxymelatonin: double blind placebo-controlled trial (2011) (0)
- The Trace of Evidence Based Medicine in Avicenna's Approaches (2016) (0)
- Will Trump’s New Sanctions Slow-down Iran’s Scientific Growth? (2018) (0)
- New generation of antidepressants in pregnant women (2007) (0)
- THE IMPORTANCE OF ETHICS IN MEDICAL BIOTECHNOLOGY (EDITORIAL) (2015) (0)
- Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trial (2022) (0)
- EDITORIAL: RESEARCH IN IRAN: HOPES AND DISAPPOINTMENTS (2017) (0)
- Expectations of Health Researchers From Academic Social Network Sites: Qualitative Study (Preprint) (2020) (0)
- EDITORIAL: PERSONALIZED MEDICINE: A TAILOR MADE MEDICINE (2014) (0)
- AMANTADINE OR METHYLPHENIDATE? COMPARISON BETWEEN THE EFFECTIVENESS AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (2011) (0)
- Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial (2022) (0)
- Response to [Palmitoylethanolamide: one molecule, different formulations] (2023) (0)
- Expectations of Health Researchers From Academic Social Network Sites: Qualitative Study (2021) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Qazvin, Iran. (2017) (0)
- Application of saffron as a neuroprotective agent (2020) (0)
- Herbal Medicine in the Treatment of Schizophrenia: A Review (2018) (0)
- Correction: A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. (2020) (0)
- Melatonin Effects in Women With Comorbidities of Overweight, Depression, and Sleep Disturbance: A Randomized Placebo Controlled Clinical Trial (2022) (0)
- RESEARCH INSTITUTIONS WITHOUT WALLS (EDITORIAL) (2014) (0)
- Title: Impact of opioid agonists on mental health in substitution treatment for opioid use disorder: A systematic review and Bayesian network meta-analysis of randomized clinical trials Running: Mental health in substitution treatment (2020) (0)
- Infectious agents and different course of multiple sclerosis: a systematic review (2018) (0)
- Author’s Reply to the Letter to the Editor by Fountoulakis (2017) (0)
- Author's response to Yang R et al.: Several concerns arise when the results are interpreted (2011) (0)
- INNOVATION AND TECHNOLOGY IN IRAN (EDITORIAL) (2017) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Golestan, Iran. (2017) (0)
- Coronavirus Reaffirmed the Need to Preserve Evidence (2021) (0)
- Evidence Based Medicine and Medical Biotechnology (2015) (0)
- Are Herbal Supplements Safe (2018) (0)
- CLINICAL TRIAL OF ADJUNCTIVE ALLOPURINOL TREATMENT IN PATIENTS WITH CHRONIC SCHIZOPHRENIA : A DOUBLE BLIND AND PLACEBO CONTROLLED TRIAL (2004) (0)
- Autistic Disorders and Medical Biotechnology (2015) (0)
- Evidence Based Medicine: Clinical Trials (2014) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Kohghilouyeh and Bouyerahmad, Iran. (2017) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Bushehr, Iran. (2017) (0)
- Fluoxetine for multiple sclerosis (2012) (0)
- A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia (2011) (0)
- 10 5-Ht 3 Antagonist for Cognition Improvement in Schizophrenia : A Double Blind , Placebo-Controlled Trial (0)
- Bidirectional Inflammation-Depression Associations and the Dynamic Intersection of Inflammation with other Pathophysiological Correlates (2022) (0)
- The Equity in Access to Coronavirus Vaccination; An Ethical, Scientific and Economic Rationale (2021) (0)
- Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial (2014) (0)
- The Importance of Ethics in Medical Biotechnology (2015) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Ilam, Iran. (2017) (0)
- An Iranian academic social network is coming (Preprint) (2019) (0)
- Toward Personalized Psychiatry: Integrating Pharmacogenetics into Psychiatry (2023) (0)
- The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era (2021) (0)
- MEDICAL BIOTECHNOLOGY AND ALZHEIMER'S DISEASE: NEW HOPES (EDITORIAL) (2016) (0)
- Research Institutions without Walls (2014) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Zanjan, Iran. (2017) (0)
- Sudden hearing loss subsequent to diarrhea: what is the missing link? (2014) (0)
- Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: a randomized, double-blind, placebo-controlled trial. (2023) (0)
- Professor Moslem Bahadori (1927-2022), a Matchless Role Model in Modern Academic Medicine in Iran. (2022) (0)
- 161-160-1-Pb (2013) (0)
- Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial (2012) (0)
- Medicinal Properties of Dye - yelding Plants: A Review (2014) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Qom, Iran. (2017) (0)
- A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Alborz, Iran. (2017) (0)
- Femicomfort in the Treatment of Premenstrual Syndromes (2022) (0)
- Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial (2015) (0)
- The Journal of Tehran University Heart Center (87-04-09).indd (2008) (0)
- Attention-Deficit/Hyperactivity Disorder and Herbal Medicine: An Evidenced Based Approach (2018) (0)
- Gabapentin as a combination treatment with lithium in adolescents with bipolar disorder: a dou-ble-blind, randomized, placebo-controlled clinical trial (2011) (0)
- Evidence Based Medicine and Herbal Medicine (2016) (0)
- Author reply (2010) (0)
- Knowledge production in Iranian cardiovascular research centers: A way to reduce the burden of disease (2020) (0)
- Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need? (2022) (0)
- Research ranking and Evaluation of Iranian Social Determinants of Health Research Centers: an effective step toward health equity (2021) (0)
- Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial (2020) (0)
- Risperidone Plus Topiramate In Children With Autistic Disorder: A Double-blind, Randomized Trial (2007) (0)
- Impact of opioid agonists on mental health in substitution treatment for opioid use disorder: A systematic review and Bayesian network meta-analysis of randomized clinical trials (2020) (0)
- Iran Science, Research & Technology Achievements since the Islamic Republic Revolution Era – (1979-2018) (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shahin Akhondzadeh?
Shahin Akhondzadeh is affiliated with the following schools:
